Clinical study of anisodine hydrobromide in treatment of cognitive impairment associated with cerebral small vessel disease

GUI Yong-kun, DU Ren-miao, SUN Yu-ying, GUO Zhen-fang, TIAN Jun-lei, LI Lin1, ZHANG Ping

PDF(1053 KB)
主办：上海医药工业研究院
　　　中国药学会
ISSN 1672-9188   CN 31-1939/R   SLYHAA
World Clinical Drug
PDF(1053 KB)
World Clinical Drug ›› 2019, Vol. 40 ›› Issue (12) : 850-857. DOI: 10.13683/j.wph.2019.12.006
Article

Clinical study of anisodine hydrobromide in treatment of cognitive impairment associated with cerebral small vessel disease

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2019, 40(12): 850-857 https://doi.org/10.13683/j.wph.2019.12.006

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1053 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉